IL‐10 producing type 2 innate lymphoid cells prolong islet allograft survival

Type 2 innate lymphoid cells (ILC2s) are a subset of ILCs with critical roles in immunoregulation. However, the possible role of ILC2s as immunotherapy against allograft rejection remains unclear. Here, we show that IL‐33 significantly prolonged islet allograft survival. IL‐33‐treated mice had eleva...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:EMBO Mol Med
Autori principali: Huang, Qingsong, Ma, Xiaoqian, Wang, Yiping, Niu, Zhiguo, Wang, Ruifeng, Yang, Fuyan, Wu, Menglin, Liang, Guining, Rong, Pengfei, Wang, Hui, Harris, David CH, Wang, Wei, Cao, Qi
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645373/
https://ncbi.nlm.nih.gov/pubmed/33034128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012305
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi